David Dranove, Walter McNerney Distinguished Professor of Health Industry Management at Northwestern University's Kellogg School of Management, has been elected to the National Academy of Medicine (NAM).
Dranove is honored for his foundational insights on how health care markets work — how they affect patients generally, vulnerable populations, health care delivery, costs and health outcomes. His work has changed scholarly and public understanding of health care markets and shaped policies toward hospitals, health insurance, physician practices and pharmaceuticals.
“I am both honored and flattered to join the National Academy of Medicine,” said Dranove. “My election to the Academy affirms the contributions made by many economists to understanding how market forces can be harnessed to improve healthcare delivery. I look forward to working with members of the Academy as we address pressing health issues facing the nation and the world.”
Founded in 1970, the National Academy of Medicine is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine. NAM has more than 2,400 members elected by their peers in recognition of outstanding achievement. Through a commitment to volunteer service, NAM members help guide the work and advance the mission of the NAM and the National Academies — to advance science, inform policy and catalyze action to achieve human health, equity and well-being.
Dranove’s research focuses on problems in industrial organization and business strategy with an emphasis on the health care industry. He has published nearly 100 research articles and book chapters and written six books, including “The Economic Evolution of American Healthcare, What’s Your Life Worth” and “Big Med.” His textbook, “Economics of Strategy,” is used by leading business schools around the world.
He has served as the lead economics expert in several high-profile healthcare antitrust cases, including FTC v. St. Luke's Healthcare System, U.S. v. Anthem and Cigna and State of California v. Sutter Health System, and regularly consults with healthcare organizations in the public and private sector. He has also served on the executive committee and board of directors of the Health Care Cost Institute and is the former treasurer of the American Society of Health Economists.